Adverum Biotechnologies Inc ADVM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/16/24 EDT
8.25UNCH (UNCH)
Volume
68,280
Close
8.25UNCH (UNCH)
Volume
285,451
52 week range
7.40 - 29.70
Loading...
  • Open8.77
  • Day High8.77
  • Day Low8.15
  • Prev Close8.75
  • 52 Week High29.70
  • 52 Week High Date02/08/24
  • 52 Week Low7.40
  • 52 Week Low Date12/29/23

Key Stats

  • Market Cap171.244M
  • Shares Out20.76M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change16.23

KEY STATS

  • Open8.77
  • Day High8.77
  • Day Low8.15
  • Prev Close8.75
  • 52 Week High29.70
  • 52 Week High Date02/08/24
  • 52 Week Low7.40
  • 52 Week Low Date12/29/23
  • Market Cap171.244M
  • Shares Out20.76M
  • 10 Day Average Volume0.33M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change16.23

RATIOS/PROFITABILITY

  • EPS (TTM)-10.23
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-1.39
  • EBITDA (TTM)-115.342M
  • ROE (TTM)-66.40%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,254.58%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adverum Biotechnologies Inc

 

Profile

MORE
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. The Company discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response...
Patrick Machado J.D.
Independent Chairman of the Board
Laurent Fischer M.D.
President, Chief Executive Officer, Director
Kishor Soparkar J.D.
Chief Operating Officer
Linda Rubinstein
Chief Financial Officer
Andrew Ramelmeier Ph.D.
Chief Technology Officer
John Rakow
General Counsel
Address
100 Cardinal Way
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
TERN
Terns Pharmaceuticals Inc
6.14UNCHUNCH
BDTX
Black Diamond Therapeutics Inc
5.24UNCHUNCH
AURA
Aura Biosciences Inc
7.20UNCHUNCH
NAUT
Nautilus Biotechnology Inc
2.92UNCHUNCH
TRML
Tourmaline Bio Inc
15.00UNCHUNCH